Market Overview

Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

Related PXLW
Thursday's After-Hours Movers: NutriSystem, LinkedIn And More
Lake Street Capital Bullish On Pixelworks, Inc.
Related SGMO
Sangamo Reports Presentation of New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storage Disorders at ASGCT
Sangamo BioSciences Provides Clinical Update On SB-728-T Program
  • Pixelworks (NASDAQ: PXLW) - up 40% - Reported that sales to Apple represented more than 10% of revenue in 2013.
  • Sangamo Biosciences (NASDAQ: SGMO) - up 17% - Announced that first-in-man study of genome editing using Sangamo's ZFN technology published In NEJM. Treatment with Sangamo's ZFN-Modified T-Cells provided functional control of HIV without antiretroviral drugs.
  • Energy Recovery (NASDAQ: ERII) - up 30% - Reports Q4 EPS of $0.13 vs $0.08 est; revenue of $23.20M vs $21.37M est.
  • Real Goods Solar (NASDAQ: RGSE) - up 5% - Selected by eight additional Massachusetts communities to expand solar.
  • Harvard Apparatus Regenerative Technology (NASDAQ: HART) - up 7% - Momentum continuing in the stock that is up 94 percent in March including this mornings gains.
  • Navidea BioPharma (NYSE: NAVB) - up 9.7% - Reported Q4 loss of $0.10/share, vs loss of $0.08/share est. Closes $30M loan with Oxford Finance, issued warrants for 391K shares at $1.92/share, will use proceeds for Lymposeek commercialization.
  • Pluristem (NASDAQ: PSTI) - up 4.5% - Gets FDA approval for commercial scale cell manufacturing process.

Posted-In: News Movers


Related Articles (ERII + NAVB)

Around the Web, We're Loving...